Clinical Trial Update: Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acetylsalicylic acid for vascular dysfunction markers in systemic sclerosis (scleroderma) patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Acetylsalicylic acid (Aspirin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Systemic Sclerosis | Phase 4 | Status: COMPLETED